Back to mobile site

Vera Therapeutics, Inc. (VERA) Misses Q3 EPS by 21c

November 9, 2022 7:50 AM EST

Vera Therapeutics, Inc. (NASDAQ: VERA) reported Q3 EPS of ($0.91), $0.21 worse than the analyst estimate of ($0.70).

For earnings history and earnings-related data on Vera Therapeutics, Inc. (VERA) click here.



Serious News for Serious Traders! Try StreetInsider.com Premium Free!

You May Also Be Interested In





Related Categories

Earnings

Related Entities

Earnings